mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.2 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.2 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.2 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
Bosutinib |
FIMM |
pan-cancer |
AAC |
-0.45 |
0.2 |